Member Info for Monty888

Stockable - There are loads of companies exceeding guidance and dropping. Take a look at “Lookers” for example. SP is lower than it’s NAV/PS today. Then there are others like Novacyt and THG as well.

Bisichi - No where near mate. Tiny company not cash generative. Lookers are Premier League Bisichi is Sunday Park side penny share.

Same with Lyons and Halifax. Cannot buy, they expecting a complete delisting so we won’t be able to sell as well.

The shorters need to close their positions and in order to do that this needs to be a tradable share on the markets. Halifax on line has blocked trading EVR. Are other brokers still allowing trading?

I’m worried the BOD, all Russian’s that could be expelled. Go back to Russia. Form a Putin supported conglomerate offer 60p / share in cash and delist - Job done. HOW: I think they own between them more than 50% of the stock so would vote in favour leaving us all nursing nasty losses & Russia ****ing a snook at UK pressure of Russian backed or owned assets

I’ll drink Stella to stellar results as well :)

I think the sediment doesn’t come from the mouth end of the horse.

Well we will get the results next month, we know they are Stella from the recent pre results trading update. There will a return to dividend and another trading update by means of the forward earnings projections. We also know 20% of the shares were traded on a market to market deal at 102p to Constellation investment vehicle - So we must be worth 102p or more by normal measures. At current trading this as close to free money as an investor will ever see. Of course we are against the tide until the very sad and terrible Ukraine invasion is over. (God Bless and look after these very Brave people as much as destiny will allow).

It’s tracking persimmon that’s all. Results will be good tomorrow probably give it another 2% or 3% kick up.

These things are normally related to overstating profits, breaking rules on “Revenue Recognition” and just plain fraudulent accounting. When look at how bad the number were to their recent updates the transformation seems unreal (it probably is). GT would have requested the corrections and DX BOD must be so corrupt they are refusing the reversals and provisions unreasonably and illegally. This has given GT no option to resign and get the hell away and loosing the lucrative business and making noise that would not be their desire. GT are cornered for sure here. Banks that fund DX would normally now appoint their own independent auditors at the cost of DX plc as would be a normal caveat In their load T&C’s. This is a bloody mess and has a long way to run. The Chair, CEO & Finance Director should “all” be forced out IMHO. If it ever re-lists again (I think it will) it’s lost investor credibility if the BOD largely remain in tact. The banks could force them out by called in the Fraud Squad and having them arrested if they don’t walk as leverage. I think after re listing there will be a drop to below 20p. If the BOD are replaced and corporate governance strengthened as a lesson learned then it could rise back above 30p. I wouldn’t hold you breath - I think it’s a circa 12 months to 30p here assuming the accounting isn’t totally fraudulent and it has no retained profits at all

The shorters are closing, Directors continue to buy (zero sellers). EV, cloud and military continue to be in serious growth phases. The war chest is ready at very low borrowing costs. The cable charts are very positive, April is not far away. Per brokers 550p recommendations the return to 480p plus will arrive this year. Very well run company, watch this space.

The shorters have got till mid April I think before they get burned so will be forced to start buying pre mid April. I hope Volex do a non standard earlier trading update which would set the shorters packing a potential loss. EV, Cloud & military markets are doing what??? I rest my case. Got 390,000 shares currently and run out of money to buy more. GLA

You are uncannily perceptive. In anything like a normalization of the market will be c. 500p by Christmas. The shorters only need a small drop to make money and AIM has fallen 35% and Volex doesn’t pander to such shenanigans- No desperation just a quite solid well run business growing organically and by smart immediately earnings enhancing acquisitions. The shorters will likely head for the hills before the next trading update. On the flip side - What a fantastic opportunity to buy a quality share at nearly half price. Broker ratings are what 510p to 550p a while back now.

Not be any fast rises should say

Issued 101 million shares at 75p - There will now fast rises after the enormous dilution and cash raising per when you saw your previous rises. Wouldn’t expect too much too soon. A lot of backers will sell down their shares as the restriction dates expire for a fast profit. Yes it’s pump and dumb for another 12 months or more.

Biosynex probably want the complementary parents and test we are waiting to get approved plus our £100m cash on our balance sheet as well as the legal dispute which is provisioned more than necessary. Biosynex is an overlap competitor and not an investment machine that invests in competitors stocks. I would think a take over bid is imminent. I would expect the 3% threshold to get to 10% in the coming days or weeks. I think we will now see a sustained upwards rise in our SP. The best thing that could happen now would be for another player to come in and start to grab 3% plus and we see the roots of a bidding war. I think fair enterprise value for an all share cash offer is around 700p in current markets.Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and specialises in the design and distribution of rapid tests (RDT). Biosynex is now the French market leader in this field.Fast and easy to use, these tests are commercialized in France and in some 90 countries through local distributors. By targeting both the public and healthcare professionals, Biosynex provides concrete effective solutions to all the latest public health issues.Since 2020, Biosynex has been at the forefront of the Covid-19 pandemic, offering innovative screening solutions (serology tests, antigen tests, self tests and PCR).

Apparently the eat in stores are booming now, Covid restrictions relaxed and thousands of Ukrainians are coming in.

Well with the float price at 500p plus cash raising a at significantly higher, a lot of II’s that supported must be wanting to see a positive return somewhere on the horizon. As MM states with data all the promised metrics are being delivered. What’s very concerning is THG could be subjected to a low ball take out if a single bidder or MM in a consortium go after it. Maybe 200 to 250p. If we get a bidding war, my sense is around 500p to 550p. I know the markets are in turmoil with the Russia prevarications, inflation and Covid etc but one has to say unless the numbers have been cooked and won’t stand up to Audit (unlikely) this is now stupidly undervalued.

Well we haven’t had any recent broker upgrades since the 110p but all logic considering NAV must see us at 150p fair value within 6 months. Enjoying the ride upwards. (Steady as she goes).

Billions and billions of shares in issue it’s just a Paper Moon.